ENTIS members from the Berlin TIS have published the largest cohort of ivabradine-exposed pregnancies to date. The case series consisted of 38 prospectively ascertained pregnancies […]
Welcome
ENTIS is a global collaborative network of Teratology Information Services. Member organisations consist of medical doctors, pharmacists, genetic counsellors and scientists all working together with the primary aim of preventing birth defects and developmental disorders which arise as a consequence of maternal or paternal perinatal exposures.
ENTIS member organisations work in three core areas:
ENTIS collaborates with researchers from a range of academic, industry and patient representative organisations. If you are interested in working with ENTIS or in joining our network, please contact us.
Alternatively, click here to learn more about ENTIS.
Latest Teratology Studies
Pregnant and breastfeeding women’s mental health status during the first wave of the COVID-19 pandemic
Collaborators from ENTIS and affiliated organisations have published the results of a web-based survey investigating how the first wave of the COVID-19 pandemic impacted the […]
Promoting collaborations to improve birth defects surveillance, research, and prevention
A joint editorial has been published in the journal Birth Defects Research from the National Birth Defects Prevention Network and the Organization of Teratology Information […]
No evidence for an increased risk of adverse pregnancy or birth outcomes following maternal pertussis vaccination in pregnancy
A collaborative of researchers from the University of Adelaide, Australia, have published a study investigating the risks of adverse pregnancy or birth outcomes following maternal […]
A demonstration of the considerable variation in stillbirth definition
Researchers from University College Cork in Ireland have performed a systematic review of the literature to explore stillbirth definitions used by high income countries around […]
Safety of direct oral anticoagulant exposure during pregnancy
A new study led from the Technische Universität Dresden in Germany has combined data from several industry and academic pharmacovigilance databases, regulatory organisations and the […]
Literature review of the safety of vedolizumab use in pregnant women with inflammatory bowel disease
A collaborative of German gastroenterology researchers have published a useful review of published data which provides evidence regarding the safety of vedolizumab use in pregnancy. […]
Pregnancy outcomes after exposure to interferon beta
An international collaboration of researchers led from StatFinn & EPID Research in Mölndal, Sweden and Espoo, Finland have published a comparative cohort study using linked […]